Negative Impact of Vapes on Public Health: WHO Calls for Urgent Action

Regulations by 2FIRSTS.ai
Dec.22.2023
Negative Impact of Vapes on Public Health: WHO Calls for Urgent Action
World Health Organization (WHO) states that there is no evidence that e-cigarettes effectively help smokers quit. Instead, evidence shows negative impacts on public health.

The World Health Organization (WHO) categorically states that there is no evidence to suggest that e-cigarettes can effectively assist community smokers in quitting smoking. On the contrary, there is existing evidence that indicates e-cigarettes have a negative impact on public health.

 

E-cigarettes have been widely available on the market and extensively promoted among young people. Currently, 34 countries have implemented bans on the sales of e-cigarettes, while 88 countries lack any minimum age restrictions for purchasing e-cigarettes. Additionally, 74 countries have no regulations in place regarding these harmful products.

 

World Health Organization Director-General Tedros Adhanom Ghebreyesus emphasized that "children are being lured into smoking and may become addicted to nicotine at a young age. I urge countries to implement strict measures to prevent the use of e-cigarettes in order to protect their citizens, especially children and adolescents.

 

E-cigarettes, which contain highly addictive nicotine, are harmful to health. While we have not yet fully understood their long-term effects on health, it has been established that they produce harmful substances, some of which are considered carcinogens, while others increase the risk of heart and lung diseases. The use of e-cigarettes may also affect brain development, leading to learning and cognitive impairments in young people. Pregnant women exposed to e-cigarettes may have adverse effects on the development of the fetus. The toxic gases in e-cigarettes also pose risks to those around the users.

 

The usage of e-cigarettes among children aged 13-15 is reported in all regions of the World Health Organization. In Canada, the prevalence of e-cigarette use among individuals aged 16-19 has doubled between 2017 and 2022. Similarly, in the UK, the number of teenagers using e-cigarettes has tripled in the past three years.

 

Research consistently indicates that even brief exposure to social media content about e-cigarettes can potentially increase both the willingness to use these products and the positive attitude towards e-cigarettes. Young people who use e-cigarettes are nearly three times more likely to use traditional cigarettes in the future.

 

The World Health Organization (WHO) has called on countries to take urgent measures to prevent the use of e-cigarettes and nicotine addiction, as well as to implement comprehensive tobacco control methods that align with each country's respective circumstances. In countries where the sale of e-cigarettes is prohibited, the WHO urges stronger enforcement of such bans and continuous monitoring to support public health interventions and ensure strict compliance. In countries where the sale of e-cigarettes as consumer products (including sales, imports, distribution, and production) is permitted, the WHO emphasizes the need for strict regulations to reduce their attractiveness and harm to the public. This includes the prohibition of all flavors, limitations on nicotine concentration and content, as well as taxation.

 

The strategy for smoking cessation should be based on the best available evidence and should be accompanied by other tobacco control measures, and it should be monitored and evaluated. According to the current evidence, the government should not allow the sales of e-cigarettes as consumer products in order to achieve the goal of smoking cessation.

 

Any government that adopts an e-cigarette smoking cessation strategy must regulate the conditions of product exposure to ensure proper clinical conditions and manage drug products (including requiring them to be distributed as pharmaceuticals). Even in such strict forms, the decision to pursue e-cigarettes as a means to achieve smoking cessation goals should only be made after reviewing domestic conditions, as well as examining smoking risks and proven cessation strategies.

 

Due to the growing prevalence of e-cigarette use, which has been found to have harmful effects on the health of children and adolescents, decisive action must be taken to prevent the use of e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
JTI Korea launched the Ploom AURA Teal Electric Pop limited edition in South Korea on September 1, 2026, marking the first dual-color design in the Ploom AURA range. The device combines a dark green body with teal accents and is accompanied by matching Front Panel, Back Cover and Pocket Bag accessories. The standalone device is priced at KRW 29,000, with three additional device-and-accessory bundles available. The release continues JTI Korea's use of limited colorways and interchangeable accessories to expand the Ploom AURA portfolio without introducing a new hardware platform.
Sep.03
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan files patent for cellulose-free nicotine pouch scaffold to replace microcrystalline cellulose
China Tobacco Yunnan Industrial Co., Ltd. has filed a patent application for a cellulose-free scaffold material for nicotine pouches, proposing a combination of bioceramic material, polydextrose and sugar alcohols to replace conventional microcrystalline cellulose and cellulose derivatives. The filing aims to address issues including powdery mouthfeel, residue and limited release control, while also reducing reliance on existing cellulose-based patent portfolios. In patent examples, one fast-release formulation reached a nicotine release rate of 50% at 10 minutes and more than 90% at 20 minutes.
Sep.02
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
R.J. Reynolds Vapor Company has introduced Vuse Pro prefilled pods in Peach, Berry, Watermelon and Fresh Mint in selected U.S. states. Vuse’s U.S. website says the pods are intended for use with existing Vuse Alto devices. Each contains 2.0 mL of e-liquid at 5.0% nicotine by weight, uses nicotine salts and is offered in two- and four-pod packs. Reynolds said the rollout includes mandatory ID scanning for every purchase, purchase limits, stronger retailer-accountability requirements and strict age-restricted marketing standards. The four pods have not received marketing authorization from the U.S. Food and Drug Administration.
Sep.10
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14